{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:14:04Z","timestamp":1791357244437,"version":"4.3.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"15","license":[{"start":{"date-parts":[[2015,4,7]],"date-time":"2015-04-07T00:00:00Z","timestamp":1428364800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s00213-015-3922-1","type":"journal-article","created":{"date-parts":[[2015,4,6]],"date-time":"2015-04-06T01:19:26Z","timestamp":1428283166000},"page":"2863-2872","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["ITI-007 demonstrates brain occupancy at serotonin 5-HT2A and dopamine D2 receptors and serotonin transporters using positron emission tomography in healthy volunteers"],"prefix":"10.1007","volume":"232","author":[{"given":"Robert E.","family":"Davis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly E.","family":"Vanover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Bra\u0161i\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Guevara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Bisuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiguo","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Raymont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Willis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Gapasin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Ronald","family":"Goldwater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Mates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean F.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,7]]},"reference":[{"issue":"3","key":"3922_CR1","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00002826-199706000-00004","volume":"20","author":"D Aizenberg","year":"1997","unstructured":"Aizenberg D, Gur S, Zemishlany Z, Granek M, Jeczmien P, Weizman A (1997) Mianserin, a 5-HT2a\/2c and alpha 2 antagonist, in the treatment of sexual dysfunction induced by serotonin reuptake inhibitors. Clin Neuropharmacol 20(3):210\u2013214","journal-title":"Clin Neuropharmacol"},{"issue":"2","key":"3922_CR2","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.pharmthera.2006.08.004","volume":"113","author":"KD Alex","year":"2007","unstructured":"Alex KD, Pehek EA (2007) Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol Ther 113(2):296\u2013320","journal-title":"Pharmacol Ther"},{"issue":"4","key":"3922_CR3","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2165\/00003495-198632040-00002","volume":"32","author":"P Benfield","year":"1986","unstructured":"Benfield P, Ward A (1986) Fluvoxamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs 32(4):313\u2013334","journal-title":"Drugs"},{"issue":"6","key":"3922_CR4","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2165\/00003495-198632060-00002","volume":"32","author":"P Benfield","year":"1986","unstructured":"Benfield P, Heel RC, Lewis SP (1986) Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs 32(6):481\u2013508","journal-title":"Drugs"},{"issue":"9","key":"3922_CR5","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1176\/ajp.2006.163.9.1580","volume":"163","author":"Z Bhagwagar","year":"2006","unstructured":"Bhagwagar Z, Hinz R, Taylor M, Fancy S, Cowen P, Grasby P (2006) Increased 5-HT(2A) receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [(11)C]MDL 100,907. Am J Psychiatry 163(9):1580\u20131587","journal-title":"Am J Psychiatry"},{"issue":"2 Suppl","key":"3922_CR6","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/0269881107088435","volume":"22","author":"C Bushe","year":"2008","unstructured":"Bushe C, Shaw M, Peveler RC (2008) A review of the association between antipsychotic use and hyperprolactinaemia. J Psychopharmacol 22(2 Suppl):46\u201355","journal-title":"J Psychopharmacol"},{"issue":"1","key":"3922_CR7","first-page":"123","volume":"2","author":"T Paulis de","year":"2001","unstructured":"de Paulis T (2001) M-100907 (Aventis). Curr Opin Investig Drugs 2(1):123\u2013132","journal-title":"Curr Opin Investig Drugs"},{"issue":"7","key":"3922_CR8","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1001\/archpsyc.1992.01820070032005","volume":"49","author":"L Farde","year":"1992","unstructured":"Farde L, Nordstrom AL, Wiesel FA, Pauli S, Halldin C, Sedvall G (1992) Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. Arch Gen Psychiatry 49(7):538\u2013544","journal-title":"Arch Gen Psychiatry"},{"issue":"1 Suppl 1","key":"3922_CR9","doi-asserted-by":"crossref","first-page":"19S","DOI":"10.1097\/00004714-199502001-00004","volume":"15","author":"L Farde","year":"1995","unstructured":"Farde L, Nyberg S, Oxenstierna G, Nakashima Y, Halldin C, Ericsson B (1995) Positron emission tomography studies on D2 and 5-HT2 receptor binding in risperidone-treated schizophrenic patients. J Clin Psychopharmacol 15(1 Suppl 1):19S\u201323S","journal-title":"J Clin Psychopharmacol"},{"issue":"12","key":"3922_CR10","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.biopsych.2005.02.028","volume":"57","author":"WG Frankle","year":"2005","unstructured":"Frankle WG, Narendran R, Huang Y, Hwang DR, Lombardo I, Cangiano C et al (2005) Serotonin transporter availability in patients with schizophrenia: a positron emission tomography imaging study with [11C]DASB. Biol Psychiatry 57(12):1510\u20131516","journal-title":"Biol Psychiatry"},{"issue":"2","key":"3922_CR11","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1124\/jpet.107.121715","volume":"322","author":"LR Gardell","year":"2007","unstructured":"Gardell LR, Vanover KE, Pounds L, Johnson RW, Barido R, Anderson GT et al (2007) ACP-103, a 5-hydroxytryptamine 2A receptor inverse agonist, improves the antipsychotic efficacy and side-effect profile of haloperidol and risperidone in experimental models. J Pharmacol Exp Ther 322(2):862\u2013870","journal-title":"J Pharmacol Exp Ther"},{"issue":"10","key":"3922_CR12","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1001\/archpsyc.60.10.974","volume":"60","author":"G Grunder","year":"2003","unstructured":"Grunder G, Carlsson A, Wong DF (2003) Mechanism of new antipsychotic medications: occupancy is not just antagonism. Arch Gen Psychiatry 60(10):974\u2013977","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"3922_CR13","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/sj.npp.1300931","volume":"31","author":"G Grunder","year":"2006","unstructured":"Grunder G, Landvogt C, Vernaleken I, Buchholz HG, Ondracek J, Siessmeier T et al (2006) The striatal and extrastriatal D2\/D3 receptor-binding profile of clozapine in patients with schizophrenia. Neuropsychopharmacology 31(5):1027\u20131035","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"3922_CR14","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1468-1331.2007.01727.x","volume":"14","author":"M Guttman","year":"2007","unstructured":"Guttman M, Boileau I, Warsh J, Saint-Cyr JA, Ginovart N, McCluskey T et al (2007) Brain serotonin transporter binding in non-depressed patients with Parkinson\u2019s disease. Eur J Neurol 14(5):523\u2013528","journal-title":"Eur J Neurol"},{"issue":"6","key":"3922_CR15","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0969-8051(00)00125-6","volume":"27","author":"J Hilton","year":"2000","unstructured":"Hilton J, Yokoi F, Dannals RF, Ravert HT, Szabo Z, Wong DF (2000) Column-switching HPLC for the analysis of plasma in PET imaging studies. Nucl Med Biol 27(6):627\u2013630","journal-title":"Nucl Med Biol"},{"issue":"1","key":"3922_CR16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.jcbfm.9600323","volume":"27","author":"R Hinz","year":"2007","unstructured":"Hinz R, Bhagwagar Z, Cowen PJ, Cunningham VJ, Grasby PM (2007) Validation of a tracer kinetic model for the quantification of 5-HT(2A) receptors in human brain with [(11)C]MDL 100,907. J Cereb Blood Flow Metab 27(1):161\u2013172","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"3922_CR17","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/syn.10268","volume":"50","author":"E Hirani","year":"2003","unstructured":"Hirani E, Sharp T, Sprakes M, Grasby P, Hume S (2003) Fenfluramine evokes 5-HT2A receptor-mediated responses but does not displace [11C]MDL 100907: small animal PET and gene expression studies. Synapse 50(3):251\u2013260","journal-title":"Synapse"},{"issue":"4","key":"3922_CR18","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1176\/appi.ajp.157.4.514","volume":"157","author":"S Kapur","year":"2000","unstructured":"Kapur S, Zipursky R, Jones C, Remington G, Houle S (2000) Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia. Am J Psychiatry 157(4):514\u2013520","journal-title":"Am J Psychiatry"},{"issue":"12","key":"3922_CR19","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1038\/sj.npp.1300836","volume":"30","author":"RM Kessler","year":"2005","unstructured":"Kessler RM, Ansari MS, Riccardi P, Li R, Jayathilake K, Dawant B, Meltzer HY (2005) Occupancy of striatal and extrastriatal dopamine D2\/D3 receptors by olanzapine and haloperidol. Neuropsychopharmacology 30(12):2283\u20132289","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"3922_CR20","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1038\/sj.npp.1301108","volume":"31","author":"RM Kessler","year":"2006","unstructured":"Kessler RM, Ansari MS, Riccardi P, Li R, Jayathilake K, Dawant B et al (2006) Occupancy of striatal and extrastriatal dopamine D2 receptors by clozapine and quetiapine. Neuropsychopharmacology 31(9):1991\u20132001","journal-title":"Neuropsychopharmacology"},{"key":"3922_CR21","doi-asserted-by":"crossref","unstructured":"Li P, Zhang Q, Robichaud AJ, Lee T, Tomesch J, Yao W, Beard JD, Snyder GL, Zhu H, Peng Y, Hendrick JP, Vanover KE, Davis RE, Mates S, Wennogle LP (2014) Discovery of a tetracyclic quinoxaline derivative as a potent and orally active multifunctional drug candidate for the treatment of neuropsychiatric and neurological disorders. J Med Chem 57(6):2670\u20132682","DOI":"10.1021\/jm401958n"},{"key":"3922_CR22","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1176\/appi.ajp.2007.06091479","volume":"164","author":"D Mamo","year":"2007","unstructured":"Mamo D, Graff A, Mizrahi R, Shammi CM, Romeyer F, Kapur S (2007) Differential effects of aripiprazole on D2, 5-HT2, and 5-HT1A receptor occupancy in patients with schizophrenia: a triple tracer PET study. Am J Psychiatry 164:1411\u20131417","journal-title":"Am J Psychiatry"},{"issue":"2","key":"3922_CR23","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/sj.npp.1300057","volume":"28","author":"GJ Marek","year":"2003","unstructured":"Marek GJ, Carpenter LL, McDougle CJ, Price LH (2003) Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders. Neuropsychopharmacology 28(2):402\u2013412","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"3922_CR24","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1038\/sj.npp.1300762","volume":"30","author":"GJ Marek","year":"2005","unstructured":"Marek GJ, Martin-Ruiz R, Abo A, Artigas F (2005) The selective 5-HT2A receptor antagonist M100907 enhances antidepressant-like behavioral effects of the SSRI fluoxetine. Neuropsychopharmacology 30(12):2205\u20132215","journal-title":"Neuropsychopharmacology"},{"issue":"13","key":"3922_CR25","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1021\/jm030026b","volume":"46","author":"CA Mathis","year":"2003","unstructured":"Mathis CA, Wang Y, Holt DP, Huang GF, Debnath ML, Klunk WE (2003) Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. J Med Chem 46(13):2740\u20132754","journal-title":"J Med Chem"},{"issue":"3","key":"3922_CR26","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00213-008-1218-4","volume":"200","author":"UD McCann","year":"2008","unstructured":"McCann UD, Szabo Z, Vranesic M, Palermo M, Mathews WB, Ravert HT et al (2008) Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (+\/-)3,4-methylenedioxymethamphetamine (\u201cecstasy\u201d) users: relationship to cognitive performance. Psychopharmacology 200(3):439\u2013450","journal-title":"Psychopharmacology"},{"issue":"2","key":"3922_CR27","first-page":"86","volume":"32","author":"JH Meyer","year":"2007","unstructured":"Meyer JH (2007) Imaging the serotonin transporter during major depressive disorder and antidepressant treatment. J Psychiatry Neurosci 32(2):86\u2013102","journal-title":"J Psychiatry Neurosci"},{"issue":"12","key":"3922_CR28","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1001\/archpsyc.61.12.1271","volume":"61","author":"JH Meyer","year":"2004","unstructured":"Meyer JH, Houle S, Sagrati S, Carella A, Hussey DF, Ginovart N et al (2004a) Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes. Arch Gen Psychiatry 61(12):1271\u20131279","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"3922_CR29","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1176\/appi.ajp.161.5.826","volume":"161","author":"JH Meyer","year":"2004","unstructured":"Meyer JH, Wilson AA, Sagrati S, Hussey D, Carella A, Potter WZ et al (2004b) Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study. Am J Psychiatry 161(5):826\u2013835","journal-title":"Am J Psychiatry"},{"issue":"6","key":"3922_CR30","first-page":"499","volume":"33","author":"JH Meyer","year":"2008","unstructured":"Meyer JH, Wilson AA, Rusjan P, Clark M, Houle S, Woodside S et al (2008) Serotonin2A receptor binding potential in people with aggressive and violent behaviour. J Psychiatry Neurosci 33(6):499\u2013508","journal-title":"J Psychiatry Neurosci"},{"issue":"4","key":"3922_CR31","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0006-3223(93)90288-O","volume":"33","author":"AL Nordstrom","year":"1993","unstructured":"Nordstrom AL, Farde L, Wiesel FA, Forslund K, Pauli S, Halldin C et al (1993) Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients. Biol Psychiatry 33(4):227\u2013235","journal-title":"Biol Psychiatry"},{"issue":"10","key":"3922_CR32","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1176\/ajp.152.10.1444","volume":"152","author":"AL Nordstrom","year":"1995","unstructured":"Nordstrom AL, Farde L, Nyberg S, Karlsson P, Halldin C, Sedvall G (1995) D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients. Am J Psychiatry 152(10):1444\u20131449","journal-title":"Am J Psychiatry"},{"issue":"6","key":"3922_CR33","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1176\/ajp.156.6.869","volume":"156","author":"S Nyberg","year":"1999","unstructured":"Nyberg S, Eriksson B, Oxenstierna G, Halldin C, Farde L (1999) Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients. Am J Psychiatry 156(6):869\u2013875","journal-title":"Am J Psychiatry"},{"key":"3922_CR34","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1176\/appi.ajp.2007.07091513","volume":"165","author":"M Poyurovsky","year":"2008","unstructured":"Poyurovsky M, Weizman R, Weizman A (2008) Aripiprazole\u2019s receptor pharmacology and extrapyramidal side effects. Am J Psychiatry 165:398","journal-title":"Am J Psychiatry"},{"issue":"1\u20132","key":"3922_CR35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0014-2999(00)00728-7","volume":"407","author":"IA Pullar","year":"2000","unstructured":"Pullar IA, Carney SL, Colvin EM, Lucaites VL, Nelson DL, Wedley S (2000) LY367265, an inhibitor of the 5-hydroxytryptamine transporter and 5-hydroxytryptamine(2A) receptor antagonist: a comparison with the antidepressant, nefazodone. Eur J Pharmacol 407(1\u20132):39\u201346","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"3922_CR36","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/sj.mp.4002149","volume":"13","author":"M Reimold","year":"2008","unstructured":"Reimold M, Batra A, Knobel A, Smolka MN, Zimmer A, Mann K et al (2008) Anxiety is associated with reduced central serotonin transporter availability in unmedicated patients with unipolar major depression: a [11C]DASB PET study. Mol Psychiatry 13(6):606\u2013613","journal-title":"Mol Psychiatry"},{"issue":"8","key":"3922_CR37","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jpsychires.2012.04.016","volume":"46","author":"GZ Reus","year":"2012","unstructured":"Reus GZ, Abelaira HM, Agostinho FR, Ribeiro KF, Vitto MF, Luciano TF et al (2012) The administration of olanzapine and fluoxetine has synergistic effects on intracellular survival pathways in the rat brain. J Psychiatr Res 46(8):1029\u20131035","journal-title":"J Psychiatr Res"},{"issue":"8","key":"3922_CR38","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s00259-005-1783-2","volume":"32","author":"MJ Ribeiro","year":"2005","unstructured":"Ribeiro MJ, Ricard M, Bourgeois S, Lievre MA, Bottlaender M, Gervais P et al (2005) Biodistribution and radiation dosimetry of [11C]raclopride in healthy volunteers. Eur J Nucl Med Mol Imaging 32(8):952\u2013958","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"3922_CR39","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.biopsych.2010.03.013","volume":"67","author":"DR Rosell","year":"2010","unstructured":"Rosell DR, Thompson JL, Slifstein M, Xu X, Frankle WG, New AS et al (2010) Increased serotonin 2A receptor availability in the orbitofrontal cortex of physically aggressive personality disordered patients. Biol Psychiatry 67(12):1154\u20131162","journal-title":"Biol Psychiatry"},{"key":"3922_CR40","first-page":"353","volume":"3","author":"BL Roth","year":"2004","unstructured":"Roth BL, Sheffler DJ, Kroeze WK (2004) Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia. Nat Rev 3:353\u2013359","journal-title":"Nat Rev"},{"issue":"1","key":"3922_CR41","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/schbul\/sbq042","volume":"38","author":"C Rummel-Kluge","year":"2012","unstructured":"Rummel-Kluge C, Komossa K, Schwarz S, Hunger H, Schmid F, Kissling W et al (2012) Second-generation antipsychotic drugs and extrapyramidal side effects: a systematic review and meta-analysis of head-to-head comparisons. Schizophr Bull 38(1):167\u2013177","journal-title":"Schizophr Bull"},{"issue":"9","key":"3922_CR42","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1176\/ajp.154.9.1209","volume":"154","author":"TE Schlaepfer","year":"1997","unstructured":"Schlaepfer TE, Pearlson GD, Wong DF, Marenco S, Dannals RF (1997) PET study of competition between intravenous cocaine and [11C]raclopride at dopamine receptors in human subjects. Am J Psychiatry 154(9):1209\u20131213","journal-title":"Am J Psychiatry"},{"issue":"2","key":"3922_CR43","first-page":"313","volume":"47","author":"M Slifstein","year":"2006","unstructured":"Slifstein M, Hwang DR, Martinez D, Ekelund J, Huang Y, Hackett E et al (2006) Biodistribution and radiation dosimetry of the dopamine D2 ligand 11C-raclopride determined from human whole-body PET. J Nucl Med 47(2):313\u2013319","journal-title":"J Nucl Med"},{"issue":"2","key":"3922_CR44","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1176\/ajp.133.2.197","volume":"133","author":"SH Snyder","year":"1976","unstructured":"Snyder SH (1976) The dopamine hypothesis of schizophrenia: focus on the dopamine receptor. Am J Psychiatry 133(2):197\u2013202","journal-title":"Am J Psychiatry"},{"key":"3922_CR45","doi-asserted-by":"crossref","unstructured":"Snyder GL, Vanover KE, Zhu H, Miller DB, O\u2019Callaghan JP, Tomesch J, Li P, et al (2015) Functional profile of a novel modulator of serotonin, dopamine, and glutamate neurotransmission. Psychopharmacology (Berl) 232(3):605\u2013621","DOI":"10.1007\/s00213-014-3704-1"},{"issue":"4","key":"3922_CR46","doi-asserted-by":"crossref","first-page":"451","DOI":"10.4088\/JCP.08m04984gre","volume":"71","author":"M Tohen","year":"2010","unstructured":"Tohen M, Case M, Trivedi MH, Thase ME, Burke SJ, Durell TM (2010) Olanzapine\/fluoxetine combination in patients with treatment-resistant depression: rapid onset of therapeutic response and its predictive value for subsequent overall response in a pooled analysis of 5 studies. J Clin Psychiatry 71(4):451\u2013462","journal-title":"J Clin Psychiatry"},{"key":"3922_CR47","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2147\/NSS.S6849","volume":"2","author":"KE Vanover","year":"2010","unstructured":"Vanover KE, Davis RE (2010) Role of 5-HT2A receptor antagonists in the treatment of insomnia. Nat Sci Sleep 2:139\u2013150","journal-title":"Nat Sci Sleep"},{"key":"3922_CR48","doi-asserted-by":"crossref","first-page":"S278","DOI":"10.1016\/S0920-9964(14)70795-9","volume":"153","author":"KE Vanover","year":"2014","unstructured":"Vanover KE, Davis RE, Ereshefsky L, Mates S (2014) Positive results for the treatment of schizophrenia: a randomized double-blind placebo- and active-controlled Phase 2 study. Schizophr Res 153:S278\u2013S279","journal-title":"Schizophr Res"},{"issue":"7","key":"3922_CR49","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1017\/S1461145710000374","volume":"13","author":"I Vernaleken","year":"2010","unstructured":"Vernaleken I, Janouschek H, Raptis M, Hellmann S, Veselinovic T, Brocheler A et al (2010) Dopamine D2\/3 receptor occupancy by quetiapine in striatal and extrastriatal areas. Int J Neuropsychopharmacol 13(7):951\u2013960","journal-title":"Int J Neuropsychopharmacol"},{"issue":"4","key":"3922_CR50","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0924-977X(96)00035-1","volume":"6","author":"ML Wadenberg","year":"1996","unstructured":"Wadenberg ML, Salmi P, Jimenez P, Svensson T, Ahlenius S (1996) Enhancement of antipsychotic-like properties of the dopamine D2 receptor antagonist, raclopride, by the additional treatment with the 5-HT2 receptor blocking agent, ritanserin, in the rat. Eur Neuropsychopharmacol 6(4):305\u2013310","journal-title":"Eur Neuropsychopharmacol"},{"issue":"4","key":"3922_CR51","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s002130000466","volume":"150","author":"ML Wadenberg","year":"2000","unstructured":"Wadenberg ML, Kapur S, Soliman A, Jones C, Vaccarino F (2000) Dopamine D2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats. Psychopharmacology 150(4):422\u2013429","journal-title":"Psychopharmacology"},{"issue":"3","key":"3922_CR52","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0091-3057(00)00483-4","volume":"68","author":"MG Wadenberg","year":"2001","unstructured":"Wadenberg MG, Browning JL, Young KA, Hicks PB (2001) Antagonism at 5-HT(2A) receptors potentiates the effect of haloperidol in a conditioned avoidance response task in rats. Pharmacol Biochem Behav 68(3):363\u2013370","journal-title":"Pharmacol Biochem Behav"},{"issue":"5","key":"3922_CR53","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0969-8051(02)00316-5","volume":"29","author":"AA Wilson","year":"2002","unstructured":"Wilson AA, Ginovart N, Hussey D, Meyer J, Houle S (2002) In vitro and in vivo characterisation of [11C]-DASB: a probe for in vivo measurements of the serotonin transporter by positron emission tomography. Nucl Med Biol 29(5):509\u2013515","journal-title":"Nucl Med Biol"},{"key":"3922_CR54","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00213-013-3103-z","volume":"229","author":"DF Wong","year":"2013","unstructured":"Wong DF, Kuwabara H, Bra\u0161i\u0107 JR, Stock T, Maini A, Gean EG et al (2013) Determination of dopamine D2 receptor occupancy by lurasidone using positron emission tomography in healthy male subjects. Psychopharmacology 229:245\u2013252","journal-title":"Psychopharmacology"},{"issue":"2","key":"3922_CR55","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0893-133X(02)00304-4","volume":"27","author":"F Yokoi","year":"2002","unstructured":"Yokoi F, Grunder G, Biziere K, Stephane M, Dogan AS, Dannals RF et al (2002) Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride. Neuropsychopharmacology 27(2):248\u2013259","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"3922_CR56","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S1053-8119(03)00017-X","volume":"18","author":"Y Zhou","year":"2003","unstructured":"Zhou Y, Endres CJ, Bra\u0161i\u0107 JR, Huang SC, Wong DF (2003) Linear regression with spatial constraint to generate parametric images of ligand-receptor dynamic PET studies with a simplified reference tissue model. NeuroImage 18(4):975\u2013989","journal-title":"NeuroImage"},{"issue":"4","key":"3922_CR57","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1016\/j.neuroimage.2009.11.028","volume":"49","author":"Y Zhou","year":"2010","unstructured":"Zhou Y, Ye W, Bra\u0161i\u0107 JR, Wong DF (2010) Multi-graphical analysis of dynamic PET. NeuroImage 49(4):2947\u20132957","journal-title":"NeuroImage"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-015-3922-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-015-3922-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-015-3922-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T16:36:47Z","timestamp":1558629407000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-015-3922-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,7]]},"references-count":57,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["3922"],"URL":"https:\/\/doi.org\/10.1007\/s00213-015-3922-1","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,7]]}}}